ELSALYS BIOTECH acquires from JAZZ PHARMACEUTICALS the worldwide rights of LEUKOTAC®
Oct 12, 2017 16:01 pm UTC| Business
ELSALYS BIOTECH acquires from JAZZ PHARMACEUTICALS the worldwide rights of LEUKOTAC®, an immunotherapy antibody with clinical benefits in steroid-resistant acute Graft-versus-Host Disease ...
Oct 12, 2017 16:00 pm UTC| Business
CLEARWATER, Fla., Oct. 12, 2017 -- Back by popular demand, the L. Ron Hubbard East Coast Theatre troupe returns to the Scientology Information Center October 14th to perform their next theatrical old-time radio show...
Appian Named a Leader in Low-Code Development Platforms For AD&D Pros by Independent Research Firm
Oct 12, 2017 16:00 pm UTC| Business
RESTON, Va., Oct. 12, 2017 -- Appian (NASDAQ:APPN), a leading Low-Code and BPM platform provider, today announced that it has been named a Leader by Forrester Research, Inc. in the independent analyst firm’s “The...
Misonix to Exhibit at NASS 2017
Oct 12, 2017 16:00 pm UTC| Business
FARMINGDALE, N.Y., Oct. 12, 2017 -- Misonix, Inc. (NASDAQ:MSON), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today announced that it will participate in the...
Oct 12, 2017 16:00 pm UTC| Business
ARCADIA, CA, Oct. 12, 2017 -- The National Fish and Wildlife Foundation (NFWF) today announced $2.5 million in grants for fire recovery and watershed restoration related to three historic fires on Angeles National...
Red Hot Chili Peppers to Perform at Stand Up for Heroes
Oct 12, 2017 16:00 pm UTC| Business
NEW YORK, Oct. 12, 2017 -- The Bob Woodruff Foundation (BWF) and New York Comedy Festival (NYCF) announced today that the Red Hot Chili Peppers will perform at this year's Stand Up for Heroes (SUFH) benefit, which...
American River Bankshares Schedules its Quarterly Conference Call
Oct 12, 2017 16:00 pm UTC| Business
SACRAMENTO, Calif., Oct. 12, 2017 -- American River Bankshares (NASDAQ:AMRB) today announced that it will host a conference call on Monday, October 23, 2017 at 1:30 p.m. Pacific Time to discuss third quarter 2017...